Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas
Mutations in isocitrate dehydrogenase (IDH) genes occur in multiple cancer types, lead to global changes in the epigenome, and drive tumorigenesis. Yet, effective strategies targeting solid tumors harboring IDH mutations remain elusive. Here, we demonstrate that IDH-mutant gliomas and cholangiocarci...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
22 April 2020
|
| In: |
Science advances
Year: 2020, Jahrgang: 6, Heft: 17 |
| ISSN: | 2375-2548 |
| DOI: | 10.1126/sciadv.aaz3221 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1126/sciadv.aaz3221 Verlag, lizenzpflichtig, Volltext: https://advances.sciencemag.org/content/6/17/eaaz3221 
|
| Verfasserangaben: | Yuxiang Wang, Aaron T. Wild, Sevin Turcan, Wei H. Wu, Carlie Sigel, David S. Klimstra, Xiaoxiao Ma, Yongxing Gong, Eric C. Holland, Jason T. Huse, Timothy A. Chan |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1699778248 | ||
| 003 | DE-627 | ||
| 005 | 20220818112216.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200604s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1126/sciadv.aaz3221 |2 doi | |
| 035 | |a (DE-627)1699778248 | ||
| 035 | |a (DE-599)KXP1699778248 | ||
| 035 | |a (OCoLC)1341328158 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wang, Yuxiang |e VerfasserIn |0 (DE-588)1046899457 |0 (DE-627)777293595 |0 (DE-576)400211122 |4 aut | |
| 245 | 1 | 0 | |a Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas |c Yuxiang Wang, Aaron T. Wild, Sevin Turcan, Wei H. Wu, Carlie Sigel, David S. Klimstra, Xiaoxiao Ma, Yongxing Gong, Eric C. Holland, Jason T. Huse, Timothy A. Chan |
| 264 | 1 | |c 22 April 2020 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.06.2020 | ||
| 520 | |a Mutations in isocitrate dehydrogenase (IDH) genes occur in multiple cancer types, lead to global changes in the epigenome, and drive tumorigenesis. Yet, effective strategies targeting solid tumors harboring IDH mutations remain elusive. Here, we demonstrate that IDH-mutant gliomas and cholangiocarcinomas display elevated DNA damage. Using multiple in vitro and preclinical animal models of glioma and cholangiocarcinoma, we developed treatment strategies that use a synthetic lethality approach targeting the reduced DNA damage repair conferred by mutant IDH using poly(adenosine 5′-diphosphate) ribose polymerase inhibitors (PARPis). The therapeutic effects are markedly enhanced by cotreatment with concurrent, localized radiation therapy. PARPi-buttressed multimodality therapies may represent a readily applicable approach that is selective for IDH-mutant tumor cells and has potential to improve outcomes in multiple cancers. - PARP inhibitor as a foundation of multimodality treatments is highly effective for IDH-mutant glioma and cholangiocarcinoma. - PARP inhibitor as a foundation of multimodality treatments is highly effective for IDH-mutant glioma and cholangiocarcinoma. | ||
| 700 | 1 | |a Wild, Aaron T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Turcan, S̨evin |e VerfasserIn |0 (DE-588)1167189582 |0 (DE-627)103087414X |0 (DE-576)511022093 |4 aut | |
| 700 | 1 | |a Wu, Wei H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sigel, Carlie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klimstra, David S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ma, Xiaoxiao |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gong, Yongxing |e VerfasserIn |4 aut | |
| 700 | 1 | |a Holland, Eric C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Huse, Jason T. |e VerfasserIn |0 (DE-588)1168672031 |0 (DE-627)1032442336 |0 (DE-576)511693605 |4 aut | |
| 700 | 1 | |a Chan, Timothy A. |e VerfasserIn |0 (DE-588)1189171171 |0 (DE-627)1667903489 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Science advances |d Washington, DC [u.a.] : Assoc., 2015 |g 6(2020,17) Artikel-Nummer eaaz3221, 14 Seiten |h Online-Ressource |w (DE-627)818494344 |w (DE-600)2810933-8 |w (DE-576)426498542 |x 2375-2548 |7 nnas |a Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas |
| 773 | 1 | 8 | |g volume:6 |g year:2020 |g number:17 |g extent:14 |a Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas |
| 856 | 4 | 0 | |u https://doi.org/10.1126/sciadv.aaz3221 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://advances.sciencemag.org/content/6/17/eaaz3221 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200604 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1167189582 |a Turcan, S̨evin |m 1167189582:Turcan, S̨evin |d 910000 |d 911100 |e 910000PT1167189582 |e 911100PT1167189582 |k 0/910000/ |k 1/910000/911100/ |p 3 | ||
| 999 | |a KXP-PPN1699778248 |e 3682520414 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1126/sciadv.aaz3221"],"eki":["1699778248"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"22 April 2020"}],"name":{"displayForm":["Yuxiang Wang, Aaron T. Wild, Sevin Turcan, Wei H. Wu, Carlie Sigel, David S. Klimstra, Xiaoxiao Ma, Yongxing Gong, Eric C. Holland, Jason T. Huse, Timothy A. Chan"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2810933-8"],"eki":["818494344"],"issn":["2375-2548"]},"origin":[{"publisherPlace":"Washington, DC [u.a.]","publisher":"Assoc.","dateIssuedKey":"2015","dateIssuedDisp":"2015-"}],"name":{"displayForm":["American Association for the Advancement of Science"]},"part":{"year":"2020","issue":"17","text":"6(2020,17) Artikel-Nummer eaaz3221, 14 Seiten","volume":"6","extent":"14"},"pubHistory":["1.2015 -"],"corporate":[{"role":"isb","display":"American Association for the Advancement of Science","roleDisplay":"Herausgebendes Organ"}],"language":["eng"],"recId":"818494344","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomasScience advances","note":["Gesehen am 13.09.21"],"title":[{"title":"Science advances","title_sort":"Science advances"}]}],"physDesc":[{"extent":"14 S."}],"title":[{"title_sort":"Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas","title":"Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas"}],"person":[{"role":"aut","display":"Wang, Yuxiang","roleDisplay":"VerfasserIn","given":"Yuxiang","family":"Wang"},{"family":"Wild","given":"Aaron T.","roleDisplay":"VerfasserIn","display":"Wild, Aaron T.","role":"aut"},{"display":"Turcan, S̨evin","roleDisplay":"VerfasserIn","role":"aut","family":"Turcan","given":"S̨evin"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Wu, Wei H.","given":"Wei H.","family":"Wu"},{"role":"aut","display":"Sigel, Carlie","roleDisplay":"VerfasserIn","given":"Carlie","family":"Sigel"},{"roleDisplay":"VerfasserIn","display":"Klimstra, David S.","role":"aut","family":"Klimstra","given":"David S."},{"given":"Xiaoxiao","family":"Ma","role":"aut","display":"Ma, Xiaoxiao","roleDisplay":"VerfasserIn"},{"family":"Gong","given":"Yongxing","roleDisplay":"VerfasserIn","display":"Gong, Yongxing","role":"aut"},{"role":"aut","display":"Holland, Eric C.","roleDisplay":"VerfasserIn","given":"Eric C.","family":"Holland"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Huse, Jason T.","given":"Jason T.","family":"Huse"},{"family":"Chan","given":"Timothy A.","display":"Chan, Timothy A.","roleDisplay":"VerfasserIn","role":"aut"}],"recId":"1699778248","language":["eng"],"note":["Gesehen am 04.06.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a WANGYUXIANTARGETINGT2220 | ||